Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Ischemic Heart Disease

  Free Subscription


16.07.2018

1 Am J Cardiol
2 Angiology
1 Ann Intern Med
1 Ann Thorac Surg
3 Arterioscler Thromb Vasc Biol
1 BMJ
1 Can J Cardiol
1 Cardiovasc Res
2 Circ Cardiovasc Interv
3 Circ Cardiovasc Qual Outcomes
2 Circ Genom Precis Med
1 Circ J
4 Circ Res
7 Circulation
3 Eur Heart J
1 Hypertension
14 Int J Cardiol
7 J Am Coll Cardiol
2 J Cardiovasc Pharmacol
1 J Clin Endocrinol Metab
1 J Clin Invest
3 J Electrocardiol
4 JAMA
1 Mayo Clin Proc
1 Mol Cell Biochem
7 PLoS One
5 Prog Cardiovasc Dis
1 Thromb Haemost


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. MOON S, Kong SH, Choi HS, Hwangbo Y, et al
    Relation of Subclinical Hypothyroidism is Associated With Cardiovascular Events and All-Cause Mortality in Adults With High Cardiovascular Risk.
    Am J Cardiol. 2018 May 16. pii: S0002-9149(18)31118.
    PubMed     Text format     Abstract available


    Angiology

  2. PARASKEVAS KI, Veith FJ, Mikhailidis DP
    The Association Between Abdominal Aortic Aneurysms With Cardiovascular and Noncardiovascular Diseases.
    Angiology. 2018 Jan 1:3319718785790. doi: 10.1177/0003319718785790.
    PubMed     Text format    

  3. DEMIRTAS K, Yayla C, Sade LE, Yildirir A, et al
    Platelet Membrane Gamma-Glutamyl Transferase-Specific Activity and the Clinical Course of Acute Coronary Syndrome.
    Angiology. 2018 Jan 1:3319718787367. doi: 10.1177/0003319718787367.
    PubMed     Text format     Abstract available


    Ann Intern Med

  4. GETAHUN D, Nash R, Flanders WD, Baird TC, et al
    Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons: A Cohort Study.
    Ann Intern Med. 2018 Jul 10. pii: 2687653. doi: 10.7326/M17-2785.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. ABDELHAMID K, Hullin R, Tozzi P, Roumy A, et al
    Huge Calcified Aneurysm of the Left Ventricle.
    Ann Thorac Surg. 2018;105:e35.
    PubMed     Text format    


    Arterioscler Thromb Vasc Biol

  6. ZHAO G, Yang W, Wu J, Chen B, et al
    Influence of a Coronary Artery Disease-Associated Genetic Variant on FURIN Expression and Effect of Furin on Macrophage Behavior.
    Arterioscler Thromb Vasc Biol. 2018 Jul 5. pii: ATVBAHA.118.311030.
    PubMed     Text format     Abstract available

  7. HAGHIKIA A, Li XS, Liman TG, Bledau N, et al
    Gut Microbiota-Dependent Trimethylamine N-Oxide Predicts Risk of Cardiovascular Events in Patients With Stroke and Is Related to Proinflammatory Monocytes.
    Arterioscler Thromb Vasc Biol. 2018 Jul 5. pii: ATVBAHA.118.311023.
    PubMed     Text format     Abstract available

  8. ASZTALOS BF, Horvath KV, Schaefer EJ
    HDL (High-Density Lipoprotein) Particles, Cell-Cholesterol Efflux, and Coronary Heart Disease Risk: The Prebeta-1 Paradox.
    Arterioscler Thromb Vasc Biol. 2018 Jul 12. pii: ATVBAHA.118.311117.
    PubMed     Text format     Abstract available


    BMJ

  9. RAY JG, Huang T, Meschino WS, Cohen E, et al
    Prenatal biochemical screening and long term risk of maternal cardiovascular disease: population based cohort study.
    BMJ. 2018;362:k2739.
    PubMed     Text format     Abstract available


    Can J Cardiol

  10. ZHU T, Lavi S, Johri AM
    Physicians' Attitudes Towards Anticoagulation for Prevention and Treatment of Left Ventricular Thrombus Following Anterior Myocardial Infarction.
    Can J Cardiol. 2018 Jun 6. pii: S0828-282X(18)30441.
    PubMed     Text format    


    Cardiovasc Res

  11. WANG Y, Liu J, Kong Q, Cheng H, et al
    Cardiomyocyte-Specific Deficiency of HSPB1 Worsens Cardiac Dysfunction by Activating NFkappaB-Mediated Leukocyte Recruitment After Myocardial Infarction.
    Cardiovasc Res. 2018 Jul 2. pii: 5047821. doi: 10.1093.
    PubMed     Text format     Abstract available


    Circ Cardiovasc Interv

  12. RAO SV
    The Future of Circulation: Cardiovascular Interventions: Changing, Creating, and Maturing.
    Circ Cardiovasc Interv. 2018;11:e007115.
    PubMed     Text format    

  13. SHEIKH AR, Abdelaal E, Sastry S, Karim S, et al
    Novel Distal Left Radial Artery Access in Anatomical Snuffbox for Recanalization of Proximal Radial Artery Total Occlusion and Percutaneous Coronary Intervention Through Left Internal Mammary Artery.
    Circ Cardiovasc Interv. 2018;11:e006579.
    PubMed     Text format    


    Circ Cardiovasc Qual Outcomes

  14. HASLAM A, Prasad V
    Multivitamins Do Not Reduce Cardiovascular Disease and Mortality and Should Not Be Taken for This Purpose: How Do We Know That?
    Circ Cardiovasc Qual Outcomes. 2018;11:e004886.
    PubMed     Text format    

  15. REMCH M, Laskaris Z, Flory J, Mora-McLaughlin C, et al
    Post-Traumatic Stress Disorder and Cardiovascular Diseases: A Cohort Study of Men and Women Involved in Cleaning the Debris of the World Trade Center Complex.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004572.
    PubMed     Text format     Abstract available

  16. KIM J, Choi J, Kwon SY, McEvoy JW, et al
    Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004224.
    PubMed     Text format     Abstract available


    Circ Genom Precis Med

  17. LEE CR, Stouffer GA
    Response by Lee and Stouffer to Letter Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention".
    Circ Genom Precis Med. 2018;11:e002258.
    PubMed     Text format    

  18. AW JWX, Tan DS, Goh LL
    Letter by Aw et al Regarding Article, "Clinical Outcomes and Sustainability of Using CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention".
    Circ Genom Precis Med. 2018;11:e002253.
    PubMed     Text format    


    Circ J

  19. SHIMODA M, Ando H, Naito K, Suzuki A, et al
    Early-Phase Vascular Healing of Bioabsorbable vs. Durable Polymer-Coated Everolimus-Eluting Stents in Patients With ST-Elevation Myocardial Infarction- 2-Week and 4-Month Analyses With Optical Coherence Tomography.
    Circ J. 2018 Jul 11. doi: 10.1253/circj.CJ-18-0230.
    PubMed     Text format     Abstract available


    Circ Res

  20. LUCAS T, Bonauer A, Dimmeler S
    RNA Therapeutics in Cardiovascular Disease.
    Circ Res. 2018;123:205-220.
    PubMed     Text format     Abstract available

  21. HERNANDEZ-BENITEZ R, Martinez-Martinez ML, Lajara J, Magistretti P, et al
    At the Heart of Genome Editing and Cardiovascular Diseases.
    Circ Res. 2018;123:221-223.
    PubMed     Text format    

  22. BANERJEE MN, Bolli R, Hare JM
    Clinical Studies of Cell Therapy in Cardiovascular Medicine: Recent Developments and Future Directions.
    Circ Res. 2018;123:266-287.
    PubMed     Text format     Abstract available

  23. GYONGYOSI M, Haller PM, Blake DJ, Martin Rendon E, et al
    Meta-Analysis of Cell Therapy Studies in Heart Failure and Acute Myocardial Infarction.
    Circ Res. 2018;123:301-308.
    PubMed     Text format     Abstract available


    Circulation

  24. KOENIG W
    Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?
    Circulation. 2018;138:150-153.
    PubMed     Text format    

  25. BEALE AL, Meyer P, Marwick TH, Lam CSP, et al
    Sex Differences in Cardiovascular Pathophysiology: Why Women Are Overrepresented in Heart Failure With Preserved Ejection Fraction.
    Circulation. 2018;138:198-205.
    PubMed     Text format     Abstract available

  26. KIKKERT WJ, Delewi R, Claessen BEPM
    Letter by Kikkert et al Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggregation With T
    Circulation. 2018;138:214-215.
    PubMed     Text format    

  27. BONACA MP, Sabatine MS
    Response by Bonaca and Sabatine to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Resea
    Circulation. 2018;138:222-223.
    PubMed     Text format    

  28. ALKHALIL M
    Letter by Alkhalil Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibitio
    Circulation. 2018;138:220-221.
    PubMed     Text format    

  29. CALABRO P, Gragnano F, Cesaro A
    Letter by Calabro et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhi
    Circulation. 2018;138:218-219.
    PubMed     Text format    

  30. IBRAHIM K, Shah R, McEvoy JW
    Response by Ibrahim et al to Letter Regarding Article, "Effect of Intravenous Fentanyl on Ticagrelor Absorption and Platelet Inhibition Among Patients Undergoing Percutaneous Coronary Intervention: The PACIFY Randomized Clinical Trial (Platelet Aggreg
    Circulation. 2018;138:216-217.
    PubMed     Text format    


    Eur Heart J

  31. KUBO T, Shinke T, Okamura T, Hibi K, et al
    Optical frequency domain imaging vs. intravascular ultrasound in percutaneous coronary intervention (OPINION trial): one-year angiographic and clinical results.
    Eur Heart J. 2017;38:3139-3147.
    PubMed     Text format     Abstract available

  32. ESCANED J, Collet C, Ryan N, Luigi De Maria G, et al
    Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study.
    Eur Heart J. 2017 Aug 26. doi: 10.1093.
    PubMed     Text format     Abstract available

  33. D'ASCENZO F, Iannaccone M, Saint-Hilary G, Bertaina M, et al
    Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients.
    Eur Heart J. 2017 Aug 11. doi: 10.1093.
    PubMed     Text format     Abstract available


    Hypertension

  34. JIA G, Aroor AR, Hill MA, Sowers JR, et al
    Role of Renin-Angiotensin-Aldosterone System Activation in Promoting Cardiovascular Fibrosis and Stiffness.
    Hypertension. 2018 Jul 9. pii: HYPERTENSIONAHA.118.11065.
    PubMed     Text format    


    Int J Cardiol

  35. NISHIMIYA K, Matsumoto Y, Wang H, Piao Z, et al
    Absence of adventitial vasa vasorum formation at the coronary segment with myocardial bridge - An optical coherence tomography study.
    Int J Cardiol. 2018;250:275-277.
    PubMed     Text format     Abstract available

  36. ONG P, Camici PG, Beltrame JF, Crea F, et al
    Response to letter from Piciche: The microvascular network connecting extracardiac arteries to the heart.
    Int J Cardiol. 2018;259:56.
    PubMed     Text format    

  37. GONG IY, Yan AT
    A new risk stratification tool for women with acute coronary syndrome.
    Int J Cardiol. 2018;259:53-54.
    PubMed     Text format    

  38. NUSDEO G, Terrosu P, Parodi G
    Optimal antiplatelet therapy after an acute coronary syndrome in the elderly: An old issue.
    Int J Cardiol. 2018;259:49-50.
    PubMed     Text format    

  39. KANUGULA AK, Thodeti CK
    AMP-activated kinase "Keaps" ischemia/reperfusion-induced necroptosis under control.
    Int J Cardiol. 2018;259:168-169.
    PubMed     Text format    

  40. KAWAMOTO H, Chieffo A, D'Ascenzo F, Jabbour RJ, et al
    Provisional versus elective two-stent strategy for unprotected true left main bifurcation lesions: Insights from a FAILS-2 sub-study.
    Int J Cardiol. 2018;250:80-85.
    PubMed     Text format     Abstract available

  41. JANSEN H, Jansch A, Breitling LP, Hoppe L, et al
    Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study.
    Int J Cardiol. 2018;250:247-252.
    PubMed     Text format     Abstract available

  42. RAGGI P, Pontone G, Andreini D
    Role of new imaging modalities in pursuit of the vulnerable plaque and the vulnerable patient.
    Int J Cardiol. 2018;250:278-283.
    PubMed     Text format     Abstract available

  43. KALA P, Cervinka P, Jakl M, Kanovsky J, et al
    OCT guidance during stent implantation in primary PCI: A randomized multicenter study with nine months of optical coherence tomography follow-up.
    Int J Cardiol. 2018;250:98-103.
    PubMed     Text format     Abstract available

  44. REDFORS B, Genereux P, Witzenbichler B, Kirtane AJ, et al
    Percutaneous coronary intervention of bifurcation lesions and platelet reactivity.
    Int J Cardiol. 2018;250:92-97.
    PubMed     Text format     Abstract available

  45. ONG P, Camici PG, Beltrame JF, Crea F, et al
    International standardization of diagnostic criteria for microvascular angina.
    Int J Cardiol. 2018;250:16-20.
    PubMed     Text format     Abstract available

  46. NAGOSHI R, Okamura T, Murasato Y, Fujimura T, et al
    Feasibility and usefulness of three-dimensional optical coherence tomography guidance for optimal side branch treatment in coronary bifurcation stenting.
    Int J Cardiol. 2018;250:270-274.
    PubMed     Text format     Abstract available

  47. VERNA E, Provasoli S, Ghiringhelli S, Morandi F, et al
    Abnormal coronary vasoreactivity in transient left ventricular apical ballooning (tako-tsubo) syndrome.
    Int J Cardiol. 2018;250:4-10.
    PubMed     Text format     Abstract available

  48. DE JAGER TAJ, Dulfer K, Radhoe S, Bergmann MJ, et al
    Predictive value of depression and anxiety for long-term mortality: differences in outcome between acute coronary syndrome and stable angina pectoris.
    Int J Cardiol. 2018;250:43-48.
    PubMed     Text format     Abstract available


    J Am Coll Cardiol

  49. GIBSON CM, Levitan B, Gibson WJ, Yee MK, et al
    Fatal or Irreversible Bleeding and Ischemic Events With Rivaroxaban in Acute Coronary Syndrome.
    J Am Coll Cardiol. 2018;72:129-136.
    PubMed     Text format     Abstract available

  50. SCHNEIDER DJ, McMahon SR, Chava S, Taatjes-Sommer HS, et al
    FcgammaRIIa: A New Cardiovascular Risk Marker.
    J Am Coll Cardiol. 2018;72:237-238.
    PubMed     Text format    

  51. LEGGIO M, D'Emidio S, Fusco A, Bendini MG, et al
    Physical Activity to Reduce Weight and Cardiovascular Events: A Wrong Focus Regarding a Shiver Contention.
    J Am Coll Cardiol. 2018;72:238-239.
    PubMed     Text format    

  52. MOHOLDT T, Lavie CJ, Nauman J
    Reply: Physical Activity to Reduce Weight and Cardiovascular Events: A Wrong Focus Regarding a Shiver Contention.
    J Am Coll Cardiol. 2018;72:239.
    PubMed     Text format    

  53. LEVY B, Clere-Jehl R, Legras A, Morichau-Beauchant T, et al
    Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction.
    J Am Coll Cardiol. 2018;72:173-182.
    PubMed     Text format     Abstract available

  54. GRANGER CB, Kochar A
    Understanding and Targeting Inflammation in Acute Myocardial Infarction: An Elusive Goal.
    J Am Coll Cardiol. 2018;72:199-201.
    PubMed     Text format    

  55. SAEED A, Feofanova EV, Yu B, Sun W, et al
    Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease.
    J Am Coll Cardiol. 2018;72:156-169.
    PubMed     Text format     Abstract available


    J Cardiovasc Pharmacol

  56. DIMITROULIS D, Golabkesh M, Naguib D, Knoop B, et al
    Safety and efficacy in Prasugrel vs. Ticagrelor treated ST-elevation myocardial infarction (STEMI) patients.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000609.
    PubMed     Text format     Abstract available

  57. ZHOU L, Liu X, Wang ZQ, Li Y, et al
    Simvastatin Treatment Protects Myocardium in Non-coronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting.
    J Cardiovasc Pharmacol. 2018 Jun 27. doi: 10.1097/FJC.0000000000000611.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  58. LYU Y, Luo Y, Li C, Guo X, et al
    Regional differences in the prevalence of coronary heart disease and stroke in patients with type 2 diabetes in China.
    J Clin Endocrinol Metab. 2018 Jul 3. pii: 5047769. doi: 10.1210/jc.2018-00422.
    PubMed     Text format     Abstract available


    J Clin Invest

  59. VIEIRA JM, Norman S, Villa Del Campo C, Cahill TJ, et al
    The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction.
    J Clin Invest. 2018 Jul 9. pii: 97192. doi: 10.1172/JCI97192.
    PubMed     Text format     Abstract available


    J Electrocardiol

  60. ALLENCHERRIL J, Fakhri Y, Engblom H, Heiberg E, et al
    Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging.
    J Electrocardiol. 2018;51:563-568.
    PubMed     Text format     Abstract available

  61. AZOZ A, Youssef A, Alshehri A, Gad A, et al
    Correlation between ST segment shift and cardiac diastolic function in patients with acute myocardial infarction.
    J Electrocardiol. 2018;51:592-597.
    PubMed     Text format     Abstract available

  62. CHEW DS, Wilton SB, Kavanagh K, Vaid HM, et al
    Fragmented QRS complexes after acute myocardial infarction are independently associated with unfavorable left ventricular remodeling.
    J Electrocardiol. 2018;51:607-612.
    PubMed     Text format     Abstract available


    JAMA

  63. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:177-183.
    PubMed     Text format     Abstract available

  64. WILKINS JT, Lloyd-Jones DM
    USPSTF Recommendations for Assessment of Cardiovascular Risk With Nontraditional Risk Factors: Finding the Right Tests for the Right Patients.
    JAMA. 2018 Jul 10. pii: 2687223. doi: 10.1001/jama.2018.9346.
    PubMed     Text format    

  65. LIN JS, Evans CV, Johnson E, Redmond N, et al
    Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018 Jul 10. pii: 2687224. doi: 10.1001/jama.2018.4242.
    PubMed     Text format     Abstract available

  66. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018 Jul 10. pii: 2687225. doi: 10.1001/jama.2018.8359.
    PubMed     Text format     Abstract available


    Mayo Clin Proc

  67. SUGRUE A, Mahowald J, Asirvatham SJ
    Hey Goglexiri, Do I Have Coronary Artery Disease?
    Mayo Clin Proc. 2018;93:818-820.
    PubMed     Text format    


    Mol Cell Biochem

  68. GANGULY R, Hasanally D, Stamenkovic A, Maddaford TG, et al
    Alpha linolenic acid decreases apoptosis and oxidized phospholipids in cardiomyocytes during ischemia/reperfusion.
    Mol Cell Biochem. 2018;437.
    PubMed     Text format     Abstract available


    PLoS One

  69. AL-DARRAJI A, Haydar D, Chelvarajan L, Tripathi H, et al
    Azithromycin therapy reduces cardiac inflammation and mitigates adverse cardiac remodeling after myocardial infarction: Potential therapeutic targets in ischemic heart disease.
    PLoS One. 2018;13:e0200474.
    PubMed     Text format     Abstract available

  70. MATSUMURA T, Terada J, Kinoshita T, Sakurai Y, et al
    Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea.
    PLoS One. 2018;13:e0195015.
    PubMed     Text format     Abstract available

  71. BATAILLE Y, Costerousse O, Bertrand OF, Moranne O, et al
    One-year mortality of patients with ST-Elevation myocardial infarction: Prognostic impact of creatinine-based equations to estimate glomerular filtration rate.
    PLoS One. 2018;13:e0199773.
    PubMed     Text format     Abstract available

  72. NORDENSKJOLD AM, Hammar P, Ahlstrom H, Bjerner T, et al
    Unrecognized myocardial infarction assessed by cardiac magnetic resonance imaging is associated with adverse long-term prognosis.
    PLoS One. 2018;13:e0200381.
    PubMed     Text format     Abstract available

  73. JOHNSON-SASSO CP, Tompkins C, Kao DP, Walker LA, et al
    Marijuana use and short-term outcomes in patients hospitalized for acute myocardial infarction.
    PLoS One. 2018;13:e0199705.
    PubMed     Text format     Abstract available

  74. SHIN H, Jang BH, Lim TH, Lee J, et al
    Diagnostic accuracy of adding copeptin to cardiac troponin for non-ST-elevation myocardial infarction: A systematic review and meta-analysis.
    PLoS One. 2018;13:e0200379.
    PubMed     Text format     Abstract available

  75. VENTURA M, Fusco D, Bontempi K, Colais P, et al
    Regional Outcome Evaluation Program (P.Re.Val.E.): Reduction of inequality in access to effective health care in the Lazio region of Italy (2012-2015).
    PLoS One. 2018;13:e0194972.
    PubMed     Text format     Abstract available


    Prog Cardiovasc Dis

  76. ELAGIZI A, Kachur S, Lavie CJ, Carbone S, et al
    An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2018 Jul 5. pii: S0033-0620(18)30130.
    PubMed     Text format     Abstract available

  77. BARRY VW, Caputo JL, Kang M
    The Joint Association of Fitness and Fatness on Cardiovascular Disease Mortality: A Meta-Analysis.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30131.
    PubMed     Text format     Abstract available

  78. ENGLISH WJ, Williams DB
    Metabolic and Bariatric Surgery: An Effective Treatment Option for Obesity and Cardiovascular Disease.
    Prog Cardiovasc Dis. 2018 Jun 25. pii: S0033-0620(18)30121.
    PubMed     Text format     Abstract available

  79. ORTEGA FB, Lavie CJ
    Introduction and Update on Obesity and Cardiovascular Diseases 2018.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30137.
    PubMed     Text format    

  80. RUIZ JR, Martinez-Tellez B, Sanchez-Delgado G, Osuna-Prieto FJ, et al
    Role of Human Brown Fat in Obesity, Metabolism and Cardiovascular Disease: Strategies to Turn Up the Heat.
    Prog Cardiovasc Dis. 2018 Jul 4. pii: S0033-0620(18)30129.
    PubMed     Text format     Abstract available


    Thromb Haemost

  81. PEDICINO D, Giglio AF, Ruggio A, Massaro G, et al
    Inflammasome, T Lymphocytes and Innate-Adaptive Immunity Crosstalk: Role in Cardiovascular Disease and Therapeutic Perspectives.
    Thromb Haemost. 2018 Jul 10. doi: 10.1055/s-0038-1666860.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: